Keyword: Daewoong Pharmaceutical

A judge orders Allergan to turn over Botox production details; A U.S. senator urges the FDA to run surprise inspections; the FDA approves Daiichi's cancer drug.

Allergan filed a trade-secrets theft investigation against rival Jeuveau to protect its Botox manufacturing secrets. That’s not exactly what happened.

Allergan is trying to blunt the launch of Botox competitor Jeuveau with allegations it was made with stolen manufacturing trade secrets.

Takeda-Zinfandel dropped an Alzheimer’s study; Shanghai Pharma will open an R&D site in the U.S.; NextCODE CEO talked about company plans.

U.S biotech Evolus alerted investors that FDA concerns with a Daewoong plant in South Korea that will make its Botox copy could delay its approval.